Fuse Oncology, a Greensboro, NC-based oncology software solutions company, closed a Series A funding of undisclosed amount.
Backers included Cone Health Ventures, of Greensboro, N.C., and Northeast Georgia Health Ventures (NGHV), of Gainesville, Ga.
The company will use the funds to accelerate expansion of its first commercial product, S!GNAL, and develop additional solutions in the radiation oncology market.
Led by James Bauler, CEO, Fuse Oncology addresses key challenges that face radiation oncology departments for a more efficient revenue cycle by automatically identifying and tracking missing documentation, incomplete tasks and orders, and wrong charges entered. Its S!GNAL technology catches issues before they materialize to improve revenue cycle and clinical staff workflows. By minimizing mistakes in the coding and documentation process, it has uncovered substantial lost revenues for providers. Additional solutions from Fuse address challenges in the patient engagement cycle to reduce average time to treatment.
The company spun out of Cone Health and signed its first revenues in quarter one of 2022.
FinSMEs
01/06/2023